4.6 Article

Concise Review: Parthenote Stem Cells for Regenerative Medicine: Genetic, Epigenetic, and Developmental Features

期刊

STEM CELLS TRANSLATIONAL MEDICINE
卷 3, 期 3, 页码 290-298

出版社

WILEY
DOI: 10.5966/sctm.2013-0127

关键词

Pluripotent stem cells; Parthenogenesis; Histocompatibility; Imprinting

资金

  1. Leducq Foundation
  2. National Institutes of Health [T32HD007133, R01HD063276, R01HD057121, R01HD059946, R01EY021214, P51OD011092]

向作者/读者索取更多资源

Embryonic stem cells (ESCs) have the potential to provide unlimited cells and tissues for regenerative medicine. ESCs derived from fertilized embryos, however, will most likely be rejected by a patient's immune system unless appropriately immunomatched. Pluripotent stem cells (PSCs) genetically identical to a patient can now be established by reprogramming of somatic cells. However, practical applications of PSCs for personalized therapies are projected to be unfeasible because of the enormous cost and time required to produce clinical-grade cells for each patient. ESCs derived from parthenogenetic embryos (pESCs) that are homozygous for human leukocyte antigens may serve as an attractive alternative for immunomatched therapies for a large population of patients. In this study, we describe the biology and genetic nature of mammalian parthenogenesis and review potential advantages and limitations of pESCs for cell-based therapies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据